Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -29.90%252.58M | 10.46%638.2M | --360.3M | 11.64%577.78M | ---- | 36.62%517.54M | 93.87%308.59M | 176.58%378.83M | 53.74%159.17M | -31.16%136.97M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 27.17%-5.85M | 9.36%-15.11M | ---8.03M | -40.12%-16.67M | ---- | -25.38%-11.9M | 11.15%-3.79M | -100.76%-9.49M | -134.62%-4.27M | -36.67%-4.73M |
| Impairment and provisions: | -80.12%2.87M | 35.03%15.48M | --14.43M | 87.27%11.46M | ---- | 8,061.33%6.12M | -88.70%85K | -92.49%75K | --752K | --999K |
| -Other impairments and provisions | -80.12%2.87M | 35.03%15.48M | --14.43M | 87.27%11.46M | ---- | 8,061.33%6.12M | -88.70%85K | -92.49%75K | --752K | --999K |
| Revaluation surplus: | -17.70%-1.66M | 3.18%-3.05M | ---1.41M | ---3.15M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other fair value changes | -17.70%-1.66M | 3.18%-3.05M | ---1.41M | ---3.15M | ---- | ---- | ---- | ---- | ---- | ---- |
| Asset sale loss (gain): | -44.63%732K | 14.79%2.97M | --1.32M | 3,019.28%2.59M | ---- | -95.68%83K | 100.00%74K | 194.63%1.92M | 276.19%37K | -20.49%652K |
| -Loss (gain) on sale of property, machinery and equipment | -44.63%732K | 14.79%2.97M | --1.32M | 3,019.28%2.59M | ---- | -71.48%83K | 100.00%74K | -55.37%291K | 276.19%37K | -20.49%652K |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.63M | ---- | ---- |
| Depreciation and amortization: | 16.13%118.36M | 14.66%216.07M | --101.92M | 10.12%188.45M | ---- | 16.02%171.13M | 17.30%83.8M | 5.47%147.5M | 6.35%71.44M | 29.07%139.85M |
| -Amortization of intangible assets | 19.73%5.89M | 16.14%11.36M | --4.92M | -4.38%9.78M | ---- | 2.33%10.23M | -3.01%5.15M | 9.02%9.99M | 36.21%5.31M | 273.40%9.17M |
| Financial expense | 20.93%61.33M | 5.64%108.96M | --50.72M | 12.56%103.14M | ---- | 19.77%91.63M | 27.96%40.82M | 3.42%76.5M | 69.99%31.9M | 86.48%73.97M |
| Special items | ---- | ---- | ---33K | 153.81%995K | ---- | -112.64%-1.85M | -83.73%1.56M | -86.57%14.62M | 712.17%9.56M | 10,191.20%108.88M |
| Operating profit before the change of operating capital | -17.50%428.36M | 11.44%963.52M | --519.22M | 11.89%864.6M | ---- | 26.69%772.75M | 60.52%431.13M | 33.59%609.95M | 44.35%268.59M | 33.01%456.6M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -211.31%-5.09M | 145.55%2.31M | ---1.64M | -917.71%-5.08M | ---- | -82.41%621K | 97.47%-47K | 168.76%3.53M | -104.96%-1.86M | -1,720.92%-5.14M |
| Accounts receivable (increase)decrease | -179.58%-15.36M | 1,560.69%20.44M | --19.3M | 97.25%-1.4M | ---- | -441.64%-50.88M | -268.67%-30.25M | 15.29%-9.39M | 46.42%-8.21M | -231.31%-11.09M |
| Accounts payable increase (decrease) | 89.54%-13.48M | -749.61%-66.87M | ---128.83M | -158.04%-7.87M | ---- | -55.22%13.56M | -92.40%-36.96M | -11.65%30.28M | -169.34%-19.21M | 76.63%34.27M |
| prepayments (increase)decrease | -79.92%4.5M | 151.60%9.97M | --22.44M | 26.57%-19.32M | ---- | 15.11%-26.31M | -54.60%4.82M | -1,408.91%-31M | 37.60%10.62M | 122.36%2.37M |
| Special items for working capital changes | 12.54%-739.77M | -185.73%-63.52M | ---845.82M | -63.45%74.09M | ---- | 20.05%202.71M | -22.23%-597.18M | 43.58%168.85M | -31.68%-488.59M | 173.75%117.6M |
| Cash from business operations | 17.94%-340.84M | -4.33%865.84M | -30.52%-415.34M | -0.81%905.02M | -39.28%-318.22M | 18.16%912.45M | 4.26%-228.48M | 29.87%772.23M | -43.98%-238.65M | 47.47%594.62M |
| Other taxs | 23.18%-64.86M | 3.33%-163.49M | 11.98%-84.43M | -46.78%-169.12M | -48.50%-95.92M | -127.93%-115.21M | -103.78%-64.59M | -155.31%-50.55M | -184.97%-31.7M | 10.96%-19.8M |
| Net cash from operations | 18.82%-405.69M | -4.56%702.36M | -20.68%-499.77M | -7.69%735.9M | -41.31%-414.14M | 10.47%797.24M | -8.41%-293.08M | 25.55%721.68M | -52.84%-270.35M | 50.88%574.82M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -27.17%5.85M | -7.90%15.11M | 21.33%8.03M | 37.90%16.41M | 74.49%6.62M | 25.38%11.9M | -11.15%3.79M | 100.76%9.49M | 134.62%4.27M | 31.97%4.73M |
| Restricted cash (increase) decrease | -155.94%-1.55M | 150.96%30.75M | ---606K | -74,600.00%-60.35M | ---- | --81K | ---- | ---- | ---- | ---- |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---40M | ---- | ---- | ---- | ---- | ---- | ---- |
| Decrease in deposits (increase) | ---- | ---- | ---- | ---- | 17.77%1.26M | ---- | 146.50%1.07M | -74.10%1.58M | -126.72%-2.3M | 75.83%6.1M |
| Sale of fixed assets | ---- | ---- | 13.33%119K | -29.30%321K | -12.50%105K | -83.09%454K | -94.59%120K | -2.15%2.69M | 25.17%2.22M | 693.06%2.74M |
| Purchase of fixed assets | -66.40%-198.54M | 55.04%-244.38M | 58.19%-119.31M | 1.43%-543.59M | 6.30%-285.36M | 48.38%-551.46M | 37.95%-304.54M | -165.08%-1.07B | -303.79%-490.83M | -126.93%-403.01M |
| Purchase of intangible assets | -26,275.15%-132.67M | -16,305.00%-278.89M | 11.44%-503K | -58.73%-1.7M | -560.47%-568K | 96.85%-1.07M | 95.58%-86K | -504.81%-33.98M | 21.38%-1.95M | 98.50%-5.62M |
| Acquisition of subsidiaries | ---- | ---46.93M | ---46.93M | ---- | ---- | ---- | ---- | ---- | ---- | ---320.74M |
| Recovery of cash from investments | -40.73%50M | -53.34%185.43M | -78.63%84.35M | -50.74%397.37M | 0.43%394.67M | -11.71%806.75M | 77.74%392.97M | 21.88%913.79M | -32.23%221.09M | 86.77%749.75M |
| Cash on investment | 95.00%-9M | -528.57%-330M | -125.00%-180M | 95.03%-52.5M | 78.20%-80M | 0.22%-1.06B | -22.61%-367M | -53.21%-1.06B | 3.58%-299.33M | -121.19%-691.43M |
| Other items in the investment business | ---- | ---- | ---- | ---36.27M | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | -12.19%-285.91M | -108.83%-668.9M | -793.86%-254.84M | 59.47%-320.31M | 113.42%36.73M | 35.95%-790.35M | 51.72%-273.68M | -87.69%-1.23B | -233.83%-566.83M | -44.36%-657.47M |
| Net cash before financing | 8.35%-691.6M | -91.95%33.45M | -99.94%-754.61M | 5,938.01%415.6M | 33.41%-377.41M | 101.34%6.88M | 32.30%-566.75M | -519.92%-512.33M | -141.49%-837.18M | -11.00%-82.65M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 101.98%990.13M | -3.07%992.49M | 82.69%490.21M | 69.97%1.02B | -35.89%268.33M | -71.21%602.39M | -71.91%418.57M | 215.38%2.09B | 188.63%1.49B | -31.12%663.43M |
| Refund | 10.96%-447.78M | -3.90%-712.16M | -199.45%-502.92M | -76.40%-685.46M | -236.16%-167.95M | 63.96%-388.58M | 90.80%-49.96M | -111.80%-1.08B | -23.37%-543.01M | -3.68%-509.11M |
| Issuing shares | 380.00%24K | --5K | --5K | ---- | ---- | -34.84%3.4M | --3.16M | -99.43%5.22M | ---- | --911.87M |
| Interest paid - financing | -1.49%-64.62M | -9.87%-133.87M | -31.56%-63.68M | -21.78%-121.85M | -7.12%-48.4M | -37.70%-100.06M | -41.65%-45.18M | -94.51%-72.66M | -59.29%-31.9M | -1.70%-37.36M |
| Dividends paid - financing | ---- | -119.51%-217.84M | ---- | -21.85%-99.24M | 97.89%-1.52M | -513.98%-81.45M | -470.95%-71.97M | -2,740.47%-13.27M | ---12.61M | 86.79%-467K |
| Absorb investment income | --9.4M | ---- | ---- | ---- | ---- | ---- | ---- | --1.47M | --1.47M | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -2,682.70%-36.34M |
| Other items of the financing business | ---- | ---- | ---- | ---- | ---- | 85.86%-85.16M | 94.07%-35.73M | -26,922.57%-602.33M | -26,922.57%-602.33M | -271.50%-2.23M |
| Net cash from financing operations | 704.35%483.33M | -172.45%-78.31M | -268.64%-79.98M | 279.72%108.09M | -77.70%47.42M | -118.61%-60.14M | -27.84%212.65M | -66.95%323.22M | 539.66%294.67M | 131.50%978.1M |
| Effect of rate | -111.71%-91K | 32.22%1.23M | -58.71%777K | -89.20%928K | -77.68%1.88M | 201.48%8.59M | 279.46%8.43M | 73.76%-8.47M | -18,892.00%-4.7M | -806,825.00%-32.27M |
| Net Cash | 75.05%-208.27M | -108.57%-44.86M | -152.91%-834.59M | 1,083.27%523.69M | 6.81%-329.99M | 71.84%-53.26M | 34.73%-354.1M | -121.12%-189.12M | -80.47%-542.5M | 157.28%895.45M |
| Begining period cash | -2.55%1.66B | 44.32%1.71B | 44.32%1.71B | -3.64%1.18B | -3.64%1.18B | -13.86%1.23B | -13.86%1.23B | 153.35%1.43B | 153.35%1.43B | 162.01%562.88M |
| Cash at the end | 66.52%1.46B | -2.55%1.66B | 2.21%874.62M | 44.32%1.71B | -3.07%855.7M | -3.64%1.18B | 0.45%882.81M | -13.86%1.23B | 235.06%878.86M | 153.35%1.43B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PwC Accounting Firm | -- | PwC Accounting Firm |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.